Emergent BioSolutions Inc. (EBS)

Emergent BioSolutions Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	436	644	518	125	592	2,230
Market Cap Growth	26.30%	24.32%	313.47%	-78.83%	-73.47%	-53.13%
Enterprise Value	860.29	1,011	1,082	873.78	1,355	2,495
Last Close Price	8.45	12.36	9.56	2.40	11.81	43.47
PE Ratio	-	13.29	-	-	-	10.71
Forward PE	-	-	-	-	51.15	7.19
PEG Ratio	-	-	-	-	11.76	0.21
PS Ratio	0.64	0.87	0.50	0.12	0.53	1.26
PB Ratio	0.84	1.23	1.07	0.19	0.43	1.38
P/TBV Ratio	0.89	1.34	1.05	0.19	0.43	1.46
P/FCF Ratio	3.22	4.11	14.47	-	-	23.21
P/OCF Ratio	2.95	3.77	8.82	-	-	6.96
EV/Sales Ratio	1.27	1.36	1.04	0.83	1.21	1.41
EV/EBITDA Ratio	5.16	4.91	144.29	-	-	5.32
EV/EBIT Ratio	11.42	10.10	-	-	-	7.31
EV/FCF Ratio	6.35	6.45	30.23	-	-	25.96
Debt / Equity Ratio	1.10	1.09	1.37	1.32	1.01	0.52
Debt / EBITDA Ratio	3.50	2.78	88.49	-	-	1.86
Debt / FCF Ratio	4.24	3.65	18.54	-	-	9.08
Net Debt / Equity Ratio	0.79	0.70	1.17	1.79	1.24	0.18
Net Debt / EBITDA Ratio	2.52	1.78	75.23	-2.00	-76.13	0.63
Net Debt / FCF Ratio	3.05	2.34	15.76	-4.51	-11.48	3.09
Asset Turnover	0.51	0.55	0.65	0.42	0.36	0.61
Inventory Turnover	0.92	1.00	2.13	2.08	1.99	2.30
Quick Ratio	1.90	2.19	1.56	0.46	0.65	2.29
Current Ratio	4.29	5.01	3.69	1.04	0.98	3.40
Return on Equity (ROE)	-1.64%	10.46%	-33.67%	-74.67%	-14.11%	14.35%
Return on Assets (ROA)	-2.89%	4.70%	-9.03%	-30.28%	-5.36%	8.46%
Return on Invested Capital (ROIC)	-3.67%	5.91%	-10.89%	-39.72%	-7.45%	12.04%
Return on Capital Employed (ROCE)	5.15%	8.29%	-9.06%	-46.72%	-7.52%	13.43%
Earnings Yield	-	7.52%	-	-	-	9.34%
FCF Yield	31.06%	24.35%	6.91%	-	-	4.31%
Buyback Yield / Dilution	1.26%	-6.98%	-3.52%	-2.20%	7.39%	-0.56%
Total Shareholder Return	1.26%	-6.98%	-3.52%	-2.20%	7.39%	-0.56%

Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q